Dilantin-125 (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Dilantin-125 drug offered from Parke-Davis Div of Pfizer Inc. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | Phenytoin |
| SUBSTANCE NAME: | PHENYTOIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1953-01-06 |
| END MARKETING DATE: | 0000-00-00 |
Dilantin-125 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dilantin-125 from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/5mL) |
| START MARKETING DATE: | 1953-01-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-2214_5b7952f5-5edb-4db0-a143-b1d89229115c |
| PRODUCT NDC: | 0071-2214 |
| APPLICATION NUMBER: | NDA008762 |
Other PHENYTOIN Pharmaceutical Manufacturers / Labelers:
